FDA names longtime cancer scientist Pazdur to lead drug center

The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, ...

FDA announces agency veteran will become top drug regulator after Tidmarsh resignation

The Food and Drug Administration on Tuesday announced 26-year-old FDA veteran Richard Pazdur will replace a top regulator who ...
MedPage Today on MSN

Longtime Oncology Official at FDA Tapped as Top Drug Regulator

A 26-year FDA scientist and administrator, Pazdur has headed the agency's Oncology Center of Excellence since its creation in ...
Healio

FDA taps ‘visionary’ oncology leader to serve as top drug regulator

The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur ...
STAT

Richard Pazdur, longtime cancer regulator, named drug center director at FDA

Pazdur replaces former Center for Drug Evaluation and Research Director George Tidmarsh, who exited the agency earlier this ...
The Associated Press on MSN

The FDA removes a long-standing warning from hormone-based menopause drugs

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...
The American Journal of Managed Care

Global Gaps in Drug Access After FDA Approval: Insights From New Study and Ethics Guidelines

Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...
MedscapeOpinion

FDA Downsizing Imperils Clinical Trial Oversight: Ethicist

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.
The Heartland InstituteOpinion

Research & Commentary: Right to Try Individualized Investigational Treatments Is the Future of Health Care in the States

As 2026 approaches, now is the time to reflect on the victories from the year and the lessons to be taken moving forward.

I went through the wringer to get menopause drugs — what we need as FDA changes ‘black box’ warning

The FDA recently announced it would remove “misleading” black box warnings for drugs that use hormones to treat menopause.
KRTV Great Falls, MT on MSN

FDA expands recall of ByHeart infant formula due to botulism concerns

FDA expands recall of ByHeart infant formula due to botulism concerns Why weren’t the Epstein files released during the Biden ...
South Florida Times

FDA removes warning from hormone-based menopause drugs

FDA sign & Bldg 21 at Entrance PHOTO COURTESY OF COMMONS.WIKIMEDIA.ORG Washington (AP) — Hormone based drugs used to treat ...